Previous 10 | Next 10 |
$75,000 Pilot Lot Payment Received for Phase I of Safer Medical of Montana Agreement; Phases II/III Commercial Scale-Up Scheduled for Early 2023 - Expected to Yield 1 st Half 2023 Revenues Over $1 Million SOUTH EASTON, MA / ACCESSWIRE / December 13, 2022 / Pressure BioSciences, Inc. (OTCQB:...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty process development and production services to the worldwide cosmetics, nutraceuticals, biotherapeutics, food/beverage, and ...
Renowned Skincare Expert Dr. Adrienne Denese Confirms PBI's UltraShear Nanoemulsion of Retinoate Profoundly Exceeds All Performance Expectations in Development of Next Generation Skincare Products SOUTH EASTON, MA / ACCESSWIRE / December 7, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PB...
Phoenix, Arizona--(Newsfile Corp. - December 5, 2022) - The Stock Day Podcast recently welcomed Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or "the Company"), a leader in the development and sale of innovative, broadly enabling, high-pressure-based instruments, consumables, and specialty proc...
Resources Continue to Pivot to UST Platform Commercialization, Achieving Major Progress and Traction; Revolutionary Nanoemulsions Technology Expected to Drive Major Growth to Profitability in 2023 Investor Call Scheduled for Tuesday, November 22, 2022 at 4:30 p.m. ET SOUTH EASTON, M...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide life sciences and other industries. The company today announced that it will host a ...
Conference Call Scheduled for Tuesday November 22 at 4:30pm ET SOUTH EASTON, MA / ACCESSWIRE / November 21, 2022 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2022 financial re...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Once again, I drew the short (no pun intended) end of the stick and must discuss stocks to sell right now. Understandably a sensitive topic and one that arouses myriad emotions, I’m just going to stick with the hard ...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide cosmetics, nutraceuticals, biotherapeutics, and other industries, today confirmed spec...
Dormant Hair Follicles to be More Effectively Revitalized by Nutrients and Therapeutics Delivered Quickly and Potently via Extremely Fine Droplet Sizes Produced from Patented UST Nanoemulsion Technology SOUTH EASTON, MA / ACCESSWIRE / October 26, 2022 / Pressure BioSciences, Inc. (OTCQB...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...